🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field. pharmaceutical-technology.com/news/sanofi-ou…

FDA approves Johnson & Johnson's Tremfya to treat Crohn's disease The decision is based on outcomes from Phase III trials involving 1,300 CD subjects. pharmaceutical-technology.com/news/jj-fda-tr…

Funding drought: how can biotech and biopharma keep trials running? Companies have been battling with a lack of private investment in recent years but could now face a lack of government funds. pharmaceutical-technology.com/features/fundi…

Menarini to enhance BPDCN detection with VisualDx's link The initiative utilises AI and machine learning technologies within the VisualDx platform. pharmaceutical-technology.com/news/menarini-…

How to manage regulatory complexities with clinical trial data Failure to comply with data regulations could have serious consequences for clinical trials. Clinicians need to invest in electronic data capture platforms that prioritise data integrity. ...

Global funding cuts reversing decades of tuberculosis progress, WHO says US government cuts at USAID have caused concern that efforts to contain infectious diseases could subside. pharmaceutical-technology.com/news/global-fu…

European agencies catch up with speedier regulatory pathways for CGTs in the US Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. pharmaceutical-technology.com/features/europ…

China conditionally approves Hutchmed's Tazverik for follicular lymphoma The approval was based on outcomes from the multicentre, open-label Phase II bridging study in the country. pharmaceutical-technology.com/news/china-hut…

Mastering compliance and copyright in healthcare and MedComms In the fast-paced world of medical communications, understanding reuse rights and copyright compliance is critical, particularly in today’s ever-evolving technological landscape. pharmaceutical-technology.com/sponsored/mast…

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis. pharmaceutical-technology.com/news/alnylam-c…

J&J boosts US operations with $55bn investment J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years. pharmaceutical-technology.com/news/jj-boosts…

AstraZeneca to invest $2.5bn in R&D centre in China The new centre will focus on early-stage research and clinical development, supported by data science and AI labs. pharmaceutical-technology.com/news/astrazene…

FDA approves IND application for Everest’s cancer vaccine The company completed subject dosing in an investigator-initiated trial of the vaccine in March 2025. pharmaceutical-technology.com/news/fda-evere…

Augustine secures $85m to advance Charcot-Marie-Tooth candidate AGT-100216 will now enter a Phase I/II proof-of-concept clinical trial for CMT disease, with patient enrolment set to begin later this year. pharmaceutical-technology.com/news/augustine…

Alberta partners Siemens and the Alberta Cancer Foundation Siemens Healthineers will contribute $122m to establish two centres of excellence and further research initiatives. pharmaceutical-technology.com/news/alberta-s…

Visitor Registration is Live! Join the UK’s leading biotech event to explore ground-breaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for free. Download your free pass at: tinyurl.com/mw4mzxt6

testing …micro-b2b-gdm-figaro1.pantheonsite.io/pharmaceutical…

Celebrate 5 years of AUTOMA+! Join pharma leaders and digital experts in Vösendorf, Austria on 24-25 November 2025. Productive networking, various types of sessions, focus exhibition, gala dinner, grand lottery and more! Register: sh.bgs.group/2pn

Congratulations to Novotech who have been honoured in the 2025 Pharmaceutical Technology Excellence Awards across three major categories: Diversity, Research and Development, and Marketing. Find out more here - bit.ly/3F0J8Ha